If you liked this article you might like

Why EpiPen, Why Now? Analysts Explain the Timing of Mylan's Trouble
Mylan Falls After Being Called Out on Price Increases -- Should You Worry?
Teva Stock Drops After Patent Invalidated
A Backlash Materializes Against Soaring EpiPen Prices